Marini JC, Erez A, Castillo L, Lee B. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes. Am J Physiol Endocrinol Metab 293: E1764-E1771, 2007. First published October 9, 2007; doi:10.1152/ajpendo.00525.2007.-The spf-ash mutation in mice results in reduced hepatic and intestinal ornithine transcarbamylase. However, a reduction in enzyme activity only translates in reduced ureagenesis and hyperammonemia when an unbalanced nitrogen load is imposed. Six-week-old wild-type control and spf-ash mutant male mice from different genetic backgrounds (B6 and ICR) were infused intravenously with and L-[ring-D5]phenylalanine to investigate the interaction between genetic background and spf-ash mutation on ureagenesis, arginine metabolism, and nitric oxide production. ICR spf-ash mice maintained ureagenesis (5.5 Ϯ 0.3 mmol ⅐ kg Ϫ1 ⅐ h Ϫ1 ) and developed mild hyperammonemia (145 Ϯ 19 mol/l) when an unbalanced nitrogen load was imposed; however, B6spf-ash mice became hyperammonemic (671 Ϯ 15 mol/l) due to compromised ureagenesis (3.4 Ϯ 0.1 mmol ⅐ kg Ϫ1 ⅐ h Ϫ1 ). Ornithine supplementation restored ureagenesis and mitigated hyperammonemia. A reduction in citrulline entry rate was observed due to the mutation in both genetic backgrounds (wild-type: 128, spf-ash: 60; SE 4.0 mol ⅐ kg Ϫ1 ⅐ h Ϫ1 ). Arginine entry rate was only reduced in B6spf-ash mice (B6 spf-ash : 332, ICR spf-ash : 453; SE 20.6 mol ⅐ kg Ϫ1 ⅐ h Ϫ1 ). Genetic background and mutation had an effect on nitric oxide production (B6: 3.4, B6 spf-ash : 2.8, ICR: 9.0, ICR spf-ash : 4.6, SE 0.7 mol ⅐ kg Ϫ1 ⅐ h Ϫ1 ). Protein breakdown was the main source of arginine during the postabsorptive state and was higher in ICR spf-ash than in B6 spf-ash mice (phenylalanine entry rate 479 and 327, respectively; SE 18 mol ⅐ kg Ϫ1 ⅐ h Ϫ1 ). Our results highlight the importance of the interaction between mutation and genetic background on ureagenesis, arginine metabolism, and nitric oxide production. These observations help explain the wide phenotypic variation of ornithine transcarbamylase deficiency in the human population.arginine; nitric oxide; urea cycle ORNITHINE TRANSCARBAMYLASE (OTC) deficiency is the most common urea cycle disorder in humans (3). The reduction in ureagenesis capacity results in high plasma ammonia concentrations and frequent hyperammonemic crises that can result in coma and even death (1). OTC is also expressed in enterocytes where it functions in the synthesis of citrulline, which is then exported into the blood, serving as the precursor for arginine synthesis by the kidney (7). The metabolism of arginine (Fig. 1) is highly compartmentalized, not only involving different organs, but different intracellular compartments and subcompartments, such as mitochondria, caveolas, and cytosol (8, 33). Furthermore, different isoforms of some of the enzymes involved [e.g., arginase, nitric oxide (NO) synthase] exist or different tissue-specific subcellular localization of the same isoform may occur (6). This compartmenta...